Successful re-administration after nano-liposomal irinotecan-induced severe hypersensitivity reaction: a case report
Ryota Kanno, Yoshitaka Saito, Yoh Takekuma, Kazuaki Harada, Yoshito Komatsu, Mitsuru Sugawara · 2025
Read Successful re-administration after nano-liposomal irinotecan-induced severe hypersensitivity reaction: a case report by Ryota Kanno, Yoshitaka Saito, Yoh Takekuma, Kazuaki Harada, Yoshito Komatsu, Mitsuru Sugawara (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12723823.txt.
Description
Ryota Kanno and five co-authors wrote this 2025 case report on restarting a cancer drug after it nearly killed the patient. A woman in her early eighties with spreading pancreatic cancer received nano-liposomal irinotecan, a second-line therapy wrapped in fatty bubbles. Five minutes into her first infusion she collapsed with breathing distress and convulsions, a severe hypersensitivity reaction.
Emergency drugs revived her. With options few and the patient determined to continue, the team tried again under armor. They used stronger premedication and a three-step infusion that crept from a third of the normal rate to full speed over an hour. No reaction came. She completed eleven cycles on the same careful schedule until the cancer progressed. The authors present the protocol as a first detailed map for continuing a valuable drug past a frightening first reaction.
Catalog record
| CREATOR | Ryota Kanno, Yoshitaka Saito, Yoh Takekuma, Kazuaki Harada, Yoshito Komatsu, Mitsuru Sugawara |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |